-
Version
-
Download
79
-
File Size
604.05 KB
-
File Count
1
-
Create Date
27/12/2018
-
Last Updated
27/12/2018
File |
---|
1545910430wpdm_Novaliq-Conducts-a-First-in-Class-Ocular-Pain-and-Anti-Inflammatory-Cannabinoid-Program.pdf | |
Download
Novaliq conducts a first-in-class ocular neuropathic pain and anti-inflammatory cannabinoid drug development program in collaboration with the university of Cologne, Germany2018-12-272018-12-27https://www.novaliq.com/wp-content/uploads/2018/07/novaliq-logo_normal.pngNovaliqhttps://www.novaliq.com/wp-content/uploads/2018/07/novaliq-logo_normal.png200px200px